Skip to main content
Premium Trial:

Request an Annual Quote

QuantumBio Receives SBIR Grant for In Silico Screening Against Bioterrorism

NEW YORK, July 7 (GenomeWeb News) - QuantumBio has been awarded a Phase I Small Business Innovation Research grant for $63,353 from the US Army Research Office to apply its in silico drug-discovery tools to the study of "next-generation tools to counter bioterrorism," the company said today.

 

QuantumBio said that the project, entitled "In Silico Screening for Biothreat Countermeasures," will be conducted in collaboration with a number of undisclosed industry partners.

 

The partners will work together to further validate the use of QMScore, QuantumBio's proprietary scoring algorithm, for developing counter-bioterrorism tools, QuantumBio said.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.